In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- 1 September 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (9), 3855-3859
- https://doi.org/10.1128/aac.00548-09
Abstract
The in vitro susceptibilities of the reference strain Leishmania donovani MHOM/ET/67/L82 to sodium stibogluconate, amphotericin B, miltefosine, and the experimental compound PX-6518 were determined for extracellular log-phase promastigotes, established axenic amastigotes, fresh spleen-derived amastigotes, and intracellular amastigotes in primary mouse peritoneal macrophages. Susceptibility to amphotericin B did not differ across the various axenic models (50% inhibitory concentrations [IC 50 ], 0.6 to 0.7 μM), and amphotericin B showed slightly higher potency against intracellular amastigotes (IC 50 , 0.1 to 0.4 μM). A similar trend was observed for miltefosine, with comparable efficacies against the extracellular (IC 50 , 0.4 to 3.8 μM) and intracellular (IC 50 , 0.9 to 4.3 μM) stages. Sodium stibogluconate, used either as Pentostam or as a crystalline substance, was inactive against all axenic stages (IC 50 , >64 μg Sb V /ml) but showed good efficacy against intracellular amastigotes (IC 50 , 22 to 28 μg Sb V /ml); the crystalline substance was about two to three times more potent (IC 50 , 9 to 11 μg Sb V /ml). The activity profile of PX-6518 was comparable to that of sodium stibogluconate, but at a much higher potency (IC 50 , 0.1 μg/ml). In conclusion, the differential susceptibility determines which in vitro models are appropriate for either drug screening or resistance monitoring of clinical field isolates. Despite the more complex and labor-intensive protocol, the current results support the intracellular amastigote model as the gold standard for in vitro Leishmania drug discovery research and for evaluation of the resistance of field strains, since it also includes host cell-mediated effects. Axenic systems can be recommended only for compounds for which no cellular mechanisms are involved, for example, amphotericin B and miltefosine.This publication has 40 references indexed in Scilit:
- In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of EndemicityAntimicrobial Agents and Chemotherapy, 2009
- Rapid fluorescent assay for screening drugs on Leishmania amastigotesJournal of Microbiological Methods, 2008
- Miltefosine Affects Lipid Metabolism in Leishmania donovani PromastigotesAntimicrobial Agents and Chemotherapy, 2007
- Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation inLeishmania donovani-Infected MacrophagesAntimicrobial Agents and Chemotherapy, 2006
- Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental modelsZeitschrift für Parasitenkunde, 2005
- Ultrastructural and cytochemical identification of megasome in Leishmania (Leishmania) chagasiZeitschrift für Parasitenkunde, 2004
- In Vitro and In Vivo Activities of a Triterpenoid Saponin Extract (PX-6518) from the Plant Maesa balansae against Visceral Leishmania SpeciesAntimicrobial Agents and Chemotherapy, 2004
- A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania speciesZeitschrift für Parasitenkunde, 2002
- In vitro activity ofTriclisia patens and some bisbenzylisoquinoline alkaloids against eishmania donovani andTrypanosoma brucei bruceiPhytotherapy Research, 2002
- New Culture Medium for Maintenance of Tsetse Tissues and Growth of Trypanosomatids*The Journal of Protozoology, 1977